The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a UK-wide consultation on proposals that would allow schools to purchase and hold spare adrenaline nasal sprays for emergency use in children…
Read more
The UK’s first needle-free adrenaline nasal spray, EURneffy® 1mg, is now available on prescription for younger children at risk of serious allergic reactions. The newly available 1 mg dose is licensed for…
Read more
Photo credit: Mast cells – Zoe Whyte, Mast cells, used with permission Mast cell diseases can go unnoticed by almost everyone, yet be unmistakable to the person living with one. Today, on…
Read more
Leo was born on 14 October 1992 and grew up as a fit, active young man who loved football, rugby and the outdoors. Although he had asthma as a child, there was…
Read more
Transforming Allergy Care:The First National Allergy Capability Framework is launched The British Society for Allergy & Clinical Immunology (BSACI) has launched the National Allergy Capability Framework (ACF), a landmark initiative designed to…
Read more
Leaving home without your adrenaline is non-negotiable. Despite the known risks, hidden barriers such as perceived social stigma mean that packing an adrenaline device often slips down the priority list for young…
Read more
What should you do if someone has anaphylaxis? We are often asked this on our helpline by people with allergies, as well as parents, friends, family members and members of the public….
Read more
An immunotherapy treatment for house dust mite allergy has been made available through the NHS in Scotland. The Scottish Medicines Consortium (SMC) has accepted Acarizax (12 SQ-HDM sublingual immunotherapy) for adults aged 18–65 with moderate…
Read more
When Josh begins his ascent of Mount Kilimanjaro later this year in aid of Anaphylaxis UK, every step he takes up Africa’s highest peak will be in memory of his brother Greg,…
Read more